Kristin Yarema - Jun 11, 2021 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Signature
/s/ David Tucker, Attorney-in-Fact for Kristin Yarema
Stock symbol
ATRA
Transactions as of
Jun 11, 2021
Transactions value $
$500,370
Form type
4
Date filed
6/15/2021, 04:02 PM
Previous filing
May 20, 2021
Next filing
Mar 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRA Common Stock Purchase $29.3K +2.02K +2.21% $14.50* 93.5K Jun 11, 2021 Direct F1
transaction ATRA Common Stock Purchase $50.7K +3.5K +3.74% $14.48* 97K Jun 14, 2021 Direct F1
transaction ATRA Common Stock Purchase $420K +28.8K +29.71% $14.58* 126K Jun 14, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person's sale of ATRA common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 761 shares, with the reporting person's sale of 761 shares of ATRA common stock at a weighted average price of $14.55 per share on May 18, 2021. The reporting person has agreed to pay to ATRA $53.27, representing the full amount of the profit realized in connection with the short-swing transaction.